Oğuzülgen, İ. K. Et Al. 2023. Realworld patient level cost effectiveness analysis of omalizumab in patients with severe allergic asthma. ERS International Congress , (Milan, Italy), 1.

Oğuzülgen, İ. K., Tugay, D., Top, M., Aydın, Ö., Bavbek, S., Damadoğlu, E., ... Öner Erkekol, F.(2023). Realworld patient level cost effectiveness analysis of omalizumab in patients with severe allergic asthma . ERS International Congress (pp.1). Milan, Italy

Oğuzülgen, İPEK Et Al. "Realworld patient level cost effectiveness analysis of omalizumab in patients with severe allergic asthma," ERS International Congress, Milan, Italy, 2023

Oğuzülgen, İPEK K. Et Al. "Realworld patient level cost effectiveness analysis of omalizumab in patients with severe allergic asthma." ERS International Congress , Milan, Italy, pp.1, 2023

Oğuzülgen, İ. K. Et Al. (2023) . "Realworld patient level cost effectiveness analysis of omalizumab in patients with severe allergic asthma." ERS International Congress , Milan, Italy, p.1.

@conferencepaper{conferencepaper, author={İPEK KIVILCIM OĞUZÜLGEN Et Al. }, title={Realworld patient level cost effectiveness analysis of omalizumab in patients with severe allergic asthma}, congress name={ERS International Congress}, city={Milan}, country={Italy}, year={2023}, pages={1} }